Prosight Management LP Has $27.44 Million Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Prosight Management LP increased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 12,113.2% in the fourth quarter, HoldingsChannel reports. The fund owned 692,000 shares of the company’s stock after purchasing an additional 686,334 shares during the period. Acadia Healthcare makes up about 7.6% of Prosight Management LP’s portfolio, making the stock its 2nd biggest position. Prosight Management LP’s holdings in Acadia Healthcare were worth $27,438,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Treasurer of the State of North Carolina raised its position in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock worth $1,586,000 after acquiring an additional 250 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares during the last quarter. Coldstream Capital Management Inc. grew its stake in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock worth $257,000 after buying an additional 303 shares during the last quarter. Covestor Ltd grew its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock worth $58,000 after buying an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. grew its stake in shares of Acadia Healthcare by 2.4% in the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock worth $549,000 after buying an additional 325 shares during the last quarter.

Acadia Healthcare Stock Down 4.5%

Shares of NASDAQ:ACHC opened at $25.72 on Thursday. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The business has a 50 day simple moving average of $26.34 and a two-hundred day simple moving average of $36.01. The firm has a market capitalization of $2.37 billion, a PE ratio of 8.43, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. During the same quarter in the previous year, the firm posted $0.84 earnings per share. The company’s revenue was up .3% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on ACHC. Guggenheim began coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target on the stock. KeyCorp cut their price target on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research note on Wednesday. Barclays cut their price target on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Royal Bank of Canada cut their price target on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Finally, Mizuho cut their target price on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.